Efficacy of Travoprost 0.004 % in Primary Open Angle Glaucoma - A clinical Study

Dr.K.V.V.Satyanarayana; Dr.G.V.Prasad; Prof. V.V.L. Narasimha Rao

Volume : VII, Issue : II, February - 2018

Efficacy of Travoprost 0.004 % in Primary Open Angle Glaucoma - A clinical Study

Dr. K. V. V. Satyanarayana, Dr. G. V. Prasad, Prof. V. V. L. Narasimha Rao

Abstract :

Aim: A prospective clinical study – To evaluate the clinical Efficacy of Travoprost 0.004 % eye drops, as Mono therapy in Primary Open Angle Glaucoma .

Material & Methods: This study conducted between Sept 2016 to August 2017, at Govt. Regional Eye Hospital, Visakhapatnam. 71 cases of 119 eyes of Primary Open Angle Glaucoma, which includes 39 Male and 32 Female patients in this study. Patients age varies between of 40 – 74 years. All cases are investigated in the lines of POAG to confirm the diagnosis.

All POAG cases are treated with Travoprost 0.004% eye drops once daily at bed time, and followed for a period of one year to evaluate for the efficacy of Travoprost 0.004% eye drops in Primary Open Angle Glaucoma.

Results:

The intra ocular pressure reduction with the treatment of Travoprost 0.004% is highly effective. There is 0 –80 Per cent (mean 40–50% ) drop in pre existing IOP. It is effective in 90% POAG cases.

Conclusions: 0.004% Travoprost eye drops proved to be the effective mono therapy in Primary Open Angle Glaucoma. It also produces ocular side effects.